CHLORPROPAMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorpropamide and what is the scope of freedom to operate?
Chlorpropamide
is the generic ingredient in three branded drugs marketed by Ani Pharms, Dava Pharms Inc, Halsey, Norvium Bioscience, Par Pharm, Rising, Sandoz, Superpharm, Usl Pharma, Watson Labs, Watson Labs Teva, and Pfizer, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for chlorpropamide.
Summary for CHLORPROPAMIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 12 |
NDAs: | 33 |
Drug Master File Entries: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 5 |
Patent Applications: | 6,983 |
DailyMed Link: | CHLORPROPAMIDE at DailyMed |
Recent Clinical Trials for CHLORPROPAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) | |
Canadian Network for Observational Drug Effect Studies, CNODES |
Medical Subject Heading (MeSH) Categories for CHLORPROPAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPROPAMIDE
US Patents and Regulatory Information for CHLORPROPAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Superpharm | CHLORPROPAMIDE | chlorpropamide | TABLET;ORAL | 088694-001 | Sep 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dava Pharms Inc | CHLORPROPAMIDE | chlorpropamide | TABLET;ORAL | 089561-001 | Sep 4, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dava Pharms Inc | CHLORPROPAMIDE | chlorpropamide | TABLET;ORAL | 089562-001 | Sep 4, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |